title: Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer.
abstract: Recently, a large number of studies have shown that the addition of proton 1H-spectroscopic imaging (1H-MRSI) and dynamic contrast enhanced imaging (DCEMR) to magnetic resonance (MR) could represent a powerful tool for the management of prostate cancer (CaP) in most of its aspects. This combination of MR techniques can substantially sustain the clinical management of patients with CaP at different levels: in particular, (1) in the initial assessment, reducing the need for more extensive biopsies and directing targeted biopsies; (2) in the definition of a biochemical progression after primary therapies, distinguishing between fibrotic reaction and local recurrence from CaP.
authors.affiliation: Department of Urology, University Sapienza, Rome, Italy. a.sciarra@lycos.it
authors.forename: Alessandro
authors.initials: A
authors.lastname: Sciarra
authors.forename: Valeria
authors.initials: V
authors.lastname: Panebianco
authors.forename: Stefano
authors.initials: S
authors.lastname: Salciccia
authors.forename: Susanna
authors.initials: S
authors.lastname: Cattarino
authors.forename: Dino
authors.initials: D
authors.lastname: Lisi
authors.forename: Alessandro
authors.initials: A
authors.lastname: Gentilucci
authors.forename: Andrea
authors.initials: A
authors.lastname: Alfarone
authors.forename: Gianna
authors.initials: G
authors.lastname: Mariotti
authors.forename: Roberto
authors.initials: R
authors.lastname: Passariello
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Gentile
mesh_terms: D006801:Humans; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology*